DTU Biosustain research communication

Press contact & experts

Our scientists are experts in a broad range of topics from antibiotic resistance, biosustainability, bioproduction of drugs, genetic modification using for instance CRISPR/Cas9 and metabolic engineering. Please contact us for further guidance to the right expert from the center.

Chief Operating Officer (COO) Bo Skjold Larsen

Management, strategy, vision, mission, politics and decision-making at the Center.

COO Bo Skjold Larsen

 

Professor Morten Sommer

Antibiotics, antibiotics resistance, development of antibiotic resistance, resistance genes, microbiome, microflora and diseases, the gut microflora, biosensors, genetic modification of bacteria, synthetic biology, CRISPR-Cas9 in bacteria, E.coli, manufacturing of vitamins in E.coli, advanced biosensors.

Professor Morten Sommer

 

Professor Alex Toftgaard Nielsen

Manufacturing of sustainable bio-chemicals in E.coli, sustainable bio-chemical production, serine, molecules for dietary supplements manufactured in E.coli, bio-chemicals and market prices.

Professor Alex Toftgaard Nielsen

 

Senior Researcher Irina Borodina

Yeast, CRISPR, genome editing, fermentation, manufacturing of bio-chemicals in yeast (resveratrol, aromatics, organic acids, sustainable plastics), insect sex pheromones, pheromones as insecticides, conversion of waste into bio-chemicals.

Senior Researcher Irina Borodina

 

Chief Information Officer (CIO) Evelyn Travnik

Computer modelling of biological data, software tools for the biotech industry, software, data, data platforms, data warehouses, machine learning, deep learning, agile, scrum, collaboration with biotech industry in connection to data/modelling.

CIO Evelyn Travnik

 

Director for 'Translational Core' Andreas Worberg (PPP)

Fermentation, upscaling of fermentation processes, design-build-test-learn workflow, collaborations with industry, commercialisation.

Andreas Worberg

 

Director of 'CHO Core' Bjørn Voldborg

Mammalian cells (CHO), manufacturing of medicine/pharmaceuticals in mammalian cells, pharmaceuticals, manufacturing of cancer medicine in CHO, fermentation of CHO, gene editing / genetic modification of CHO using CRISPR-Cas9.

Director Bjørn Voldborg

Contact

Anne Wärme Lykke
Communications Officer
DTU Biosustain
+45 21 12 37 70

Contact

Anders Østerby Mønsted
Communications Officer
DTU Biosustain
+45 24 67 79 47